1,1,2,2-Tetrakis(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethene, 97%, 250mg

Methyl 2-bromo-5-chlorothiazole-4-carboxylate, 95.0%, 250mg

N,N-Diméthylformamide (DMF), 2,5 l

Methyl 6-aminopyridazine-3-carboxylate, 95.0%, 5g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamic Acid>98.0%(HPLC)(T)1g

5-Methyl-2-pyridin-3-yl-thiazole-4-carboxylic acid, 95.0%, 1g

N-(3-Bromo-4-fluorophenyl)acetamide, 95.0%, 25g

2-Bromobenzonitrile, 99.0%, 25g

1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide hydrochloride, 95.0%, 1g

2-(((Benzyloxy)carbonyl)amino)propanoic acid, 95.0%, 10g

Fmoc-Lys(ivDde)-OH, 95%, 5g

tert-Butyl 4-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 250mg

4,4,4-Trifluoro-1-(1-methyl-1H-pyrazol-4-yl)-butane-1,3-dione, 500mg